Product Stability Data; Notice of Pilot Project, 28353-28354 [E6-7391]
Download as PDF
28353
Federal Register / Vol. 71, No. 94 / Tuesday, May 16, 2006 / Notices
These data collections are part of the
BSF evaluation, which is an important
opportunity to learn if well-designed
interventions can help low-income
couples develop the knowledge and
relationship skills that research has
shown are associated with healthy
marriages. BSF programs will provide
instruction and support to improve
marriage and relationship skills and
enhance couples’ understanding of
marriage. In addition, BSF programs
will provide links to a variety of other
services that could help couples sustain
a healthy relationship (e.g., employment
assistance). The BSF evaluation uses an
experimental design that randomly
assigns couples who volunteer to
participate in BSF programs to a
program or to a control group.
The BSF evaluation has two parts, an
implementation study and an impact
study. For the implementation study,
the BSF evaluation will use the
interview and focus-group protocols to
document how the programs worked
and the experiences of staff and couples
enrolled. For the impact study, the BSF
evaluation will use telephone surveys to
determine whether the BSF programs
helped couples form healthier
marriages.
Respondents: for the implementation
study, respondents will be BSF program
managers and staff, couples who
participated in the BSF group sessions,
and couples who dropped out of the
program or never participated in the
BSF groups. Information from staff will
be obtained in face-to-face interviews.
Information from participating couples
will be collected in focus groups. Nonparticipating couples and couples who
dropped out of the program will be
interviewed by phone. For the impact
study, the respondents for the 15-month
survey will be all couples in the BSF
evaluation. They will be interviewed by
telephone. Both types of information
collection will take place over about a
24-month period.
ANNUAL BURDEN ESTIMATES
Number of
respondents
Instrument
Number of
responses per
respondent
Average
burden hours
per response
Total burden
hours
Implementation Study
Staff interview protocol ....................................................................................
Focus group protocol .......................................................................................
Telephone interview protocol (non-participants/dropouts) ...............................
126
70
84
1
1
1
1.5
1.5
.17
189
105
14
15-month Survey (females) .............................................................................
15-month Survey (males) ................................................................................
1,434
1,434
1
1
.91
.83
1,305
1,190
Estimated Total Annual Burden Hours .....................................................
........................
........................
........................
2,803
Impact Study
sroberts on PROD1PC70 with NOTICES
Additional Information: Copies of the
proposed collection may be obtained by
writing to the Administration for
Children and Families, Office of
Administration, Office of Information
Services, 370 L’Enfant Promenade, SW.,
Washington, DC 20447, Attn: ACF
Reports Clearance Officer. All requests
should be identified by the title of the
information collection. E-mail address:
infocollection@acf.hhs.gov.
OMB Comment: OMB is required to
make a decision concerning the
collection of information between 30
and 60 days after publication of this
document in the Federal Register.
Therefore, a comment is best assured of
having its full effect if OMB receives it
within 30 days of publication. Written
comments and recommendations for the
proposed information collection should
be sent directly to the following: Office
of Management and Budget, Paperwork
Reduction Project, Attn: Desk Officer for
ACF, E-mail address:
Katherine_T._Astrich@omb.eop.gov.
Dated: May 11, 2006.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 06–4584 Filed 5–15–06; 8:45 am]
BILLING CODE 4184–01–M
VerDate Aug<31>2005
16:06 May 15, 2006
Jkt 208001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2006N–0181]
Product Stability Data; Notice of Pilot
Project
AGENCY:
Food and Drug Administration,
HHS
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is seeking
volunteers to participate in a pilot
project involving the testing of a Health
Level 7 (HL7) data interchange standard
for the submission of product stability
data to FDA to facilitate the review of
this data. Using the data interchange
standards and the analytical tools will
allow consistent data presentation to the
agency and allow a reviewer to more
efficiently and consistently display and
evaluate product stability data
submitted in electronic format.
DATES: Submit written or electronic
requests to participate in the pilot
project by July 17, 2006. Comments on
this pilot project can be submitted at
any time.
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
Submit written requests to
participate to Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. Submit
electronic requests to https://
www.fda.gov/dockets/ecomments.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Norman Schmuff, Food and Drug
Administration, Center for Drug
Evaluation and Research, 10903 New
Hampshire Ave., Bldg. 22, rm.
2472,Silver Spring, MD 20993–0002,
norman.schmuff@fda.hhs.gov or
Norman Gregory, Food and Drug
Administration, Center for Veterinary
Medicine (HFV–143), Rockville, MD
20857, norman.gregory@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I . Background
Applicants provide product stability
information in marketing applications
and other submissions to the various
centers of FDA. This information is
currently provided in paper documents
or as a series of portable document
format (PDF) files. In January 2001, a
format for presenting product stability
data in extensible markup language
(XML) and a prototype of a review tool
E:\FR\FM\16MYN1.SGM
16MYN1
28354
Federal Register / Vol. 71, No. 94 / Tuesday, May 16, 2006 / Notices
for evaluating stability information were
demonstrated at an FDA public meeting.
Subsequently, work has been
underway in the Regulated Clinical
Research Information Management
technical committee in HL7 to refine the
data design presented at the meeting
with the goal of developing an XML
standard for the exchange of product
stability data based on the HL7 version
3 reference information model. HL7 is
an international, open, American
National Standards Institute (ANSI)
accredited standards development
organization that focuses on standards
for the exchange of information related
to health care. The Stability Data
Standard was adopted by HL7 by a vote
of the full membership in May 2005 and
was adopted as an ANSI standard in
October 2005. FDA is currently
considering the adoption of the standard
as a voluntary standard for transmission
of stability data in new drug
applications, abbreviated new drug
applications, investigational new drugs,
new animal drug applications,
abbreviated new animal drug
applications, and investigational new
animal drugs.
The purpose of this pilot project is to
assist in the evaluation of the data
interchange standard, provide data for
testing the analytical tools designed to
facilitate the review of product stability
data and to obtain feedback from
reviewers and pharmaceutical
companies on the creation and use of
standardized product stability data.
sroberts on PROD1PC70 with NOTICES
II. Pilot Project Description
This pilot project is part of an effort
to improve the process for submitting
and reviewing product stability data by
increasing the consistency of the
process (by establishing a uniform
procedure). A consistent look and feel is
expected to facilitate the review of this
data. Eventually, there is the
expectation that a detailed data
interchange standard for the submission
of product stability data will be defined
based on the HL7 model. As the HL7
model was developed via a
collaboration between industry and
FDA, certain portions of the model may
be useful for industry, but not needed in
submissions to FDA. Consequently, the
HL7 stability model may be adopted in
whole or in part. Participants in this
pilot project will have the opportunity
not only to assist FDA in testing the
stability data interchange standard, but
will also be able to familiarize
themselves with the process at an early
stage of development. Only a few
participants are needed for this pilot.
VerDate Aug<31>2005
16:06 May 15, 2006
Jkt 208001
1. Initial Approach
Because a limited number of
voluntary participants are needed, the
agency will use its discretion in
choosing volunteers, basing this
selection on a firm’s experience with the
preparation of product stability
documents and data submissions to the
different centers at FDA. During the
pilot project specific technical
instructions for providing the product
stability data for testing will be made
available to participants. Participants in
the pilot project will be asked to provide
the product stability data as described
in the technical instructions and to
provide technical feedback.
2. Scope
Existing expectations for the
submission of product stability data will
not be waived, suspended, or modified
for purposes of this pilot project.
However, aside from metadata
associated with the XML instance, there
will be no additional data expectations
beyond those data usually submitted in
applications. The pilot project will test
the preparation and use of the submitted
product stability data.
3. How to Participate and Submit
Comments
Written and electronic requests to
volunteer should be submitted to the
docket number found in the heading of
this document. In addition to requests to
participate, interested persons can
submit to the Division of Dockets
Management (see ADDRESSES) written or
electronic comments regarding this pilot
project. Two paper copies of any
comments are to be submitted, except
that individuals can submit one paper
copy. Comments are to be identified
with the docket number found in
brackets in the heading of this
document. We will consider all received
comments in making a determination on
adopting the data interchange standard
as a voluntary standard for the
electronic submission of product
stability data.
Dated: May 8, 2006.
Jefrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E6–7391 Filed 5–15–06; 8:45 am]
BILLING CODE 4160–01–S
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Environmental
Health Sciences, Proposed Collection;
Comment Request; The Head Off
Environmental Asthma in Louisiana
(HEAL) Study
SUMMARY: In compliance with the
requirement of section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
National Institute of Environmental
Health Sciences (NIEHS), the National
Institutes of Health (NIH) will publish
periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
Proposed Collection
Title: The Head Off Environmental
Asthma in Louisiana (HEAL) Study.
Type of Information Collection
Request: New collection.
Need and Use of Information
Collection: The purpose of the HEAL
Study is to design, implement and
evaluate a case management program to
intervene in asthma morbidity and
examine the genetic and environmental
risk factors in children in post-Katrina
New Orleans. Asthma is the most
common chronic disease among
children in the United States; it is the
number one reason children miss school
and the second leading cause of
emergency department visits after
accidents and injuries. Asthma
prevalence has been increasing
dramatically, especially among minority
inner-city children, where rates as high
as 24% have been observed in some
urban census areas. Overall rates of
asthma have also increased in postKatrina Louisiana children from 14%
(2003) to 18% (2006) according to
results from the Louisiana Child &
Family Health Study, and may be even
higher for minority and underprivileged
children or children residing in certain
geographical areas that were affected by
post-Katrina flooding. For the HEAL
Study, a school-based screening survey
will be given to children (5 to 12 years
of age) in the public and/or private
elementary schools in New Orleans.
This survey will take about 15 minutes
to complete and contains questions
concerning physician diagnosed asthma,
asthma morbidity, healthcare, and
current housing situation, as well as
recent and planned changes in housing.
The major purpose of the school-based
survey will be to identify up to 1,000
E:\FR\FM\16MYN1.SGM
16MYN1
Agencies
[Federal Register Volume 71, Number 94 (Tuesday, May 16, 2006)]
[Notices]
[Pages 28353-28354]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-7391]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 2006N-0181]
Product Stability Data; Notice of Pilot Project
AGENCY: Food and Drug Administration, HHS
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is seeking volunteers
to participate in a pilot project involving the testing of a Health
Level 7 (HL7) data interchange standard for the submission of product
stability data to FDA to facilitate the review of this data. Using the
data interchange standards and the analytical tools will allow
consistent data presentation to the agency and allow a reviewer to more
efficiently and consistently display and evaluate product stability
data submitted in electronic format.
DATES: Submit written or electronic requests to participate in the
pilot project by July 17, 2006. Comments on this pilot project can be
submitted at any time.
ADDRESSES: Submit written requests to participate to Division of
Dockets Management (HFA-305), Food and Drug Administration, 5630
Fishers Lane, rm. 1061, Rockville, MD 20852. Submit electronic requests
to https://www.fda.gov/dockets/ecomments.
FOR FURTHER INFORMATION CONTACT: Norman Schmuff, Food and Drug
Administration, Center for Drug Evaluation and Research, 10903 New
Hampshire Ave., Bldg. 22, rm. 2472,Silver Spring, MD 20993-0002,
norman.schmuff@fda.hhs.gov or Norman Gregory, Food and Drug
Administration, Center for Veterinary Medicine (HFV-143), Rockville, MD
20857, norman.gregory@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I . Background
Applicants provide product stability information in marketing
applications and other submissions to the various centers of FDA. This
information is currently provided in paper documents or as a series of
portable document format (PDF) files. In January 2001, a format for
presenting product stability data in extensible markup language (XML)
and a prototype of a review tool
[[Page 28354]]
for evaluating stability information were demonstrated at an FDA public
meeting.
Subsequently, work has been underway in the Regulated Clinical
Research Information Management technical committee in HL7 to refine
the data design presented at the meeting with the goal of developing an
XML standard for the exchange of product stability data based on the
HL7 version 3 reference information model. HL7 is an international,
open, American National Standards Institute (ANSI) accredited standards
development organization that focuses on standards for the exchange of
information related to health care. The Stability Data Standard was
adopted by HL7 by a vote of the full membership in May 2005 and was
adopted as an ANSI standard in October 2005. FDA is currently
considering the adoption of the standard as a voluntary standard for
transmission of stability data in new drug applications, abbreviated
new drug applications, investigational new drugs, new animal drug
applications, abbreviated new animal drug applications, and
investigational new animal drugs.
The purpose of this pilot project is to assist in the evaluation of
the data interchange standard, provide data for testing the analytical
tools designed to facilitate the review of product stability data and
to obtain feedback from reviewers and pharmaceutical companies on the
creation and use of standardized product stability data.
II. Pilot Project Description
This pilot project is part of an effort to improve the process for
submitting and reviewing product stability data by increasing the
consistency of the process (by establishing a uniform procedure). A
consistent look and feel is expected to facilitate the review of this
data. Eventually, there is the expectation that a detailed data
interchange standard for the submission of product stability data will
be defined based on the HL7 model. As the HL7 model was developed via a
collaboration between industry and FDA, certain portions of the model
may be useful for industry, but not needed in submissions to FDA.
Consequently, the HL7 stability model may be adopted in whole or in
part. Participants in this pilot project will have the opportunity not
only to assist FDA in testing the stability data interchange standard,
but will also be able to familiarize themselves with the process at an
early stage of development. Only a few participants are needed for this
pilot.
1. Initial Approach
Because a limited number of voluntary participants are needed, the
agency will use its discretion in choosing volunteers, basing this
selection on a firm's experience with the preparation of product
stability documents and data submissions to the different centers at
FDA. During the pilot project specific technical instructions for
providing the product stability data for testing will be made available
to participants. Participants in the pilot project will be asked to
provide the product stability data as described in the technical
instructions and to provide technical feedback.
2. Scope
Existing expectations for the submission of product stability data
will not be waived, suspended, or modified for purposes of this pilot
project. However, aside from metadata associated with the XML instance,
there will be no additional data expectations beyond those data usually
submitted in applications. The pilot project will test the preparation
and use of the submitted product stability data.
3. How to Participate and Submit Comments
Written and electronic requests to volunteer should be submitted to
the docket number found in the heading of this document. In addition to
requests to participate, interested persons can submit to the Division
of Dockets Management (see ADDRESSES) written or electronic comments
regarding this pilot project. Two paper copies of any comments are to
be submitted, except that individuals can submit one paper copy.
Comments are to be identified with the docket number found in brackets
in the heading of this document. We will consider all received comments
in making a determination on adopting the data interchange standard as
a voluntary standard for the electronic submission of product stability
data.
Dated: May 8, 2006.
Jefrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E6-7391 Filed 5-15-06; 8:45 am]
BILLING CODE 4160-01-S